Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) Short Interest Up 56.3% in October

Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) saw a significant growth in short interest during the month of October. As of October 31st, there was short interest totalling 13,600 shares, a growth of 56.3% from the October 15th total of 8,700 shares. Based on an average daily volume of 14,500 shares, the days-to-cover ratio is currently 0.9 days. Currently, 0.4% of the shares of the company are short sold.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Cryo-Cell International stock. Geode Capital Management LLC grew its stake in shares of Cryo-Cell International, Inc. (NYSEAMERICAN:CCEL) by 68.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 39,860 shares of the company’s stock after buying an additional 16,203 shares during the period. Geode Capital Management LLC owned 0.49% of Cryo-Cell International worth $254,000 at the end of the most recent reporting period. Institutional investors own 10.44% of the company’s stock.

Cryo-Cell International Price Performance

Shares of CCEL opened at $8.43 on Friday. The firm has a market capitalization of $67.95 million, a P/E ratio of -7.95 and a beta of 0.43. Cryo-Cell International has a one year low of $3.67 and a one year high of $9.50.

Cryo-Cell International (NYSEAMERICAN:CCEL) last released its quarterly earnings results on Tuesday, October 15th. The company reported $0.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.02 by $0.11. Cryo-Cell International had a negative return on equity of 42.06% and a negative net margin of 28.03%. The business had revenue of $8.07 million during the quarter.

Cryo-Cell International Dividend Announcement

The firm also recently announced a — dividend, which will be paid on Friday, November 29th. Shareholders of record on Friday, November 15th will be issued a dividend of $0.25 per share. The ex-dividend date of this dividend is Friday, November 15th.

About Cryo-Cell International

Cryo-Cell International, Inc engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases.